Informatie:
Fout:
ID
34165
Beschrijving
Comparison of Contrast-enhanced Spectral Mammography (CESM) to MRI in Screening High Risk Women for Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02275871
Link
https://clinicaltrials.gov/show/NCT02275871
Trefwoorden
Versies (1)
- 14-01-19 14-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
14 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT02275871
Eligibility Breast Cancer NCT02275871
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT02275871
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
women
boolean
ID.2
Item
age > or equal to 30 years
boolean
ID.3
Item
high risk (>20% lifetime risk)
boolean
ID.4
Item
has a bilateral mammogram within the last 7 months
boolean
ID.5
Item
has had a same day high risk screening mri
boolean
ID.6
Item
participants who have a known allergy or contraindication to iodinated contrast.
boolean
ID.7
Item
participants who have a known allergy to food or medications.
boolean
ID.8
Item
participants who have renal insufficiency or failure.
boolean
ID.9
Item
participants who are pregnant or breastfeeding.
boolean
ID.10
Item
participants with a concurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia.
boolean